Michael A. Loh

Michael A. Loh is an American immunologist and virologist recognized for his pioneering research on the human immune system, particularly in the contexts of HIV/AIDS and cancer immunotherapy. His work has significantly advanced the understanding of T cell biology and exhaustion, providing foundational insights for developing novel therapeutic strategies. Loh has held prominent research positions at the University of California, San Francisco and the Gladstone Institutes, contributing to major collaborative projects like the NIH-funded BEAT-HIV Delaney Collaboratory.

Early life and education

Michael A. Loh pursued his undergraduate studies at the University of California, Berkeley, where he developed an interest in molecular biology. He subsequently earned his medical degree from the University of California, San Francisco, a leading institution in biomedical research. His early training was influenced by the burgeoning scientific response to the AIDS epidemic in San Francisco, steering his focus toward virology and immunology. This academic foundation at premier University of California campuses positioned him for a career at the intersection of basic science and clinical translation.

Career

Loh began his research career as a postdoctoral fellow at the University of California, San Francisco, working within its renowned Department of Medicine. He later established his independent laboratory at the Gladstone Institutes, a biomedical research organization affiliated with UCSF. His career has been characterized by long-term collaborations with leading scientists in the field, including those within the BEAT-HIV Delaney Collaboratory, a major research initiative aimed at finding a cure for HIV. Throughout his tenure, Loh has also contributed to educational missions, mentoring fellows and graduate students through programs at the UCSF Graduate Division.

Research and contributions

Loh's research has primarily focused on the mechanisms of T cell dysfunction during chronic viral infections and cancer. His seminal work has elucidated pathways of T cell exhaustion, a state of immune dysfunction observed in diseases like HIV/AIDS and hepatitis C virus infection. This research has direct implications for the field of cancer immunotherapy, particularly for enhancing checkpoint inhibitor therapies such as those targeting the PD-1 pathway. His laboratory utilizes advanced techniques in genomics, single-cell RNA sequencing, and CRISPR gene editing to map the epigenetic and transcriptional landscapes of exhausted T cells. These contributions have been published in high-impact journals including Cell, Nature, and Science.

Awards and honors

In recognition of his scientific contributions, Michael A. Loh has received several prestigious awards and fellowships. These include a career development award from the National Institutes of Health and a young investigator award from the American Association of Immunologists. His research has been consistently funded by grants from the NIH, including support from the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. Loh's work within the BEAT-HIV collaboratory has also been recognized through invitations to speak at major international conferences such as the Conference on Retroviruses and Opportunistic Infections.

Personal life

Michael A. Loh maintains a private personal life. He is known to be an advocate for public science communication and has participated in community outreach events in the San Francisco Bay Area to discuss advances in HIV research. Outside of his laboratory, he has expressed interests in hiking and the outdoors, often exploring the regional parks of Northern California.

Category:American immunologists Category:University of California, San Francisco alumni Category:Virologists